Modular Medical Enters Collaboration with Phillips-Medisize for Insulin Delivery Technology

Development stage insulin delivery technology company, Modular Medical, Inc. (Nasdaq:MODD), has entered a collaboration with Phillips-Medisize, a Molex company and a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic, medtech and specialty consumer devices.

Phillips-Medisize will provide Modular Medical with design, development and high-volume manufacturing capabilities.

Kevin Schmid, COO of Modular Medical, said, “This collaboration has provided Modular Medical with an accelerated development process, while simultaneously preparing for significant scalability and market launch readiness.  The collaboration is preparing Modular Medical to quickly market its new delivery technology for insulin-requiring patients with diabetes.”

Highlights

Phillips-Medisize leveraged its global, diversified supplier base and deep medical device and diabetes disease experience to design and develop manufacturing and assembly for the MODD1 Insulin Delivery System.

Specific expertise provided by Phillips-Medisize included conventional, two-shot and insert injection molding, as well as other services such as packaging, electronics design and manufacturing, and assembly operations.

John Horgan, Vice President and General Manager, Global Medical Business Unit, at Phillips-Medisize, said, “Through this collaboration, we were able to meet Modular Medical’s aggressive development schedule to commercialize the MODD1 Insulin Delivery System, a patient-centric innovation designed to support critical treatment for the growing number of patients who rely upon insulin to manage their diabetes.”

About Modular Medical

Modular Medical, Inc. (Nasdaq:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Our mission is to improve access to the highest standard of glycemic control for people with diabetes, taking it beyond “superusers” and providing “diabetes care for the rest of us.”

Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding MODD, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.

Share This Article

 

About the Author

Modular Medical Enters Collaboration with Phillips-Medisize for Insulin Delivery Technology

Editor Prism MarketView